Explore the Spring 2026 Issue of BioMatters®: From Discovery to Patient
Michigan’s life sciences ecosystem continues to drive innovation across the full spectrum of drug discovery, development, and delivery — and the Spring 2026 issue of BioMatters® showcases the companies and technologies helping shape that future.
Centered around the theme “From Discovery to Patient: Michigan’s Biopharma Engine at Work,” this issue highlights the organizations advancing breakthrough science, strengthening clinical development, improving drug delivery, and expanding the infrastructure needed to support the next generation of therapies.
Featured stories include:
- NSF, highlighting how global regulatory and testing expertise continues to support Michigan’s growing life sciences industry.
- Innovative Research, providing the biological materials that power research labs around the world.
- SciTech Development, advancing ST-001 nanoFenretinide™ as a promising new oncology therapy.
- Corium Innovations, developing transdermal drug delivery technologies designed to provide continuous 7-day treatment.
- Peptinovo Biopharma, leveraging its PALM™ platform to rethink targeted chemotherapy delivery.
- Proteos, entering a new era of drug discovery through expanded recombinant protein and cryo-EM capabilities.
- Blue Parachute, helping biopharma companies strengthen clinical operations and trial oversight.
- Charles River Laboratories, supporting the science behind safer and more effective therapies through preclinical research and development.
- PharmOptima, advancing precision preclinical drug development through specialized bioanalytical and in-vivo research services.
- Sartorius, investing in Michigan’s future with a new Center of Excellence for Bioanalytics in Ann Arbor.
The issue also features Michigan bio-industry data, emerging company spotlights, and insights into the state’s expanding bioscience ecosystem.
Read the full Spring 2026 issue of BioMatters® and explore the companies helping position Michigan as a leader in life sciences innovation.
